Five Years of Sword-Forging: Shouldering China's Backbone in Heavy Ion Therapy ——A Five-Year Chronic
Five Years of Sword-Forging: Shouldering China's Backbone in Heavy Ion Therapy
——A Five-Year Chronicle of High-Quality Development at Gansu Wuwei Cancer Hospital's Heavy Ion Center
Five years mark a breakthrough from zero to one—when China's first domestically developed heavy ion therapy system took root in the northwest, forming a strategic synergy between the Wuwei and Lanzhou dual centers.
Five years embody a bold venture into uncharted territory—armed with a pioneering spirit, the center has overcome multiple "bottleneck" technologies, revolutionizing traditional diagnosis and treatment models through eight globally unprecedented core innovations.
Five years reflect a commitment to putting lives first—with a healing original aspiration, the center has deeply cultivated clinical practice, granting over 2,000 patients with complex tumors a new lease on life.
Five years showcase the responsibility of wisdom-sharing—driven by dual engines of technological innovation and knowledge dissemination, a series of publications established the world's first heavy ion medical standard system, transforming research into a universally applicable "Chinese solution."
Five years demonstrate an open and collaborative vision—embracing diverse expertise, the center has converged global wisdom, fostering deep integration between top-tier experts and cutting-edge concepts to build an international heavy ion medical innovation hub. In the construction of a global health community, it has carved an indelible "Chinese coordinate."
Technology Leadership
Forging Multiple "World's First" Breakthroughs with Core Competence
Through five years of relentless progress, the Heavy Ion Center at Gansu Wuwei Cancer Hospital has continuously broken new ground in technological innovation, achieving multiple "world's first" milestones. It stands as the only hospital globally operating two heavy ion therapy systems, and with the launch of the Lanzhou Heavy Ion Center under its management half a year ago, a powerful dual-center synergy has been formed—significantly expanding treatment capacity and outreach.
In treatment technology, the center has consistently pushed boundaries: it leads the world in the number of single-fraction treatments completed within a single day, drastically shortening therapy cycles and alleviating patient suffering. Pioneering global firsts include:
Precision heavy ion therapy under respiratory gating control,
Bladder cancer treatment with precise bladder volume management,
Single-session heavy ion therapy with surgically placed spacers between organs and tumors.
Each breakthrough embodies the ingenuity and dedication of the research and clinical teams, offering new hope to countless patients with complex conditions. Domestically, the center developed China’s first 360° rotating and height-adjustable ion therapy chair, providing robust support for precision treatment. Globally, it achieved:
The first successful heavy ion treatments for multiple cardiac tumors,
The first integration of heavy ion therapy with comprehensive, lifelong physical and mental health management.
From cutting-edge techniques to patient-centered care philosophy, the center is steering the evolution of heavy ion therapy worldwide. To date, it has completed over 2,000 heavy ion treatments, filling critical gaps in international medicine and setting a benchmark in global oncology.
High-Frequency Oscillatory Ventilation-Controlled Precision Heavy Ion Therapy Technology
Rotating & Adjustable Heavy Ion Therapy Chair
People-Centric Quality Enhancement
Differential Pricing System Activates Inclusive Momentum for Heavy Ion Therapy
On the path to democratizing heavy ion therapy technology, the Heavy Ion Center at Gansu Wuwei Cancer Hospital has placed "people's health" at its core, innovatively establishing a tiered pricing system to transform cutting-edge medical technology into accessible and affordable public welfare.
Leveraging the coordinated development of its dual centers in Wuwei and Lanzhou, the center implements a dual-track model of "precision care + inclusive benefits":
- Wuwei Heavy Ion Center:Continues to specialize in precision heavy ion treatment for complex and rare cases.Fully implements a comprehensive, lifelong health management system, offering zero out-of-pocket services including:Physical and mental wellness programsCultural therapyRural rehabilitation retreatsSpecialized rehabilitation therapiesMaintains its existing heavy ion therapy pricing structure.
- Lanzhou Heavy Ion Center:Introduces an optimized pricing model:First treatment: ¥49,500Subsequent treatments: ¥16,500 per sessionSingle-course cap: ¥198,000Designed to accommodate personalized treatment needs across diverse patient groups.
Patients enrolled in heavy ion-specific insurance from major national insurers can claim reimbursements at both centers.
This innovative approach achieves precision resource allocation through differentiated positioning, ensuring:
✔ Tailored care for complex cases
✔ Expanded access to world-leading heavy ion technology
By transitioning heavy ion therapy from "elite exclusivity" to "inclusive accessibility", the center pioneers a synergistic development model combining "technological innovation + social equity". It provides a replicable blueprint for enhancing high-end medical accessibility in China and advancing the Healthy China initiative.
Research Empowerment
Clinical Studies Drive Technological Innovation
In the journey of advancing heavy ion therapy, the Heavy Ion Center at Gansu Wuwei Cancer Hospital has consistently positioned clinical research as its core engine, adhering to a trinity development path of "scientific breakthroughs, clinical practice, and translational outcomes" to propel the iterative evolution of heavy ion technology.
The center focuses on high-incidence cancers such as liver cancer, esophageal cancer, and lung cancer, systematically launching eight clinical research projects on heavy ion therapy. Through an innovative "challenge-based research mobilization" mechanism, it brings together top-tier global research teams to tackle critical areas including:
✔ Treatment protocol optimization
✔ Efficacy evaluation system refinement
✔ Complication prevention and control
As China’s pioneer in heavy ion medical research, the center not only delivers world-class treatments but also feeds clinical practice through forward-looking scientific investment. It will conduct eight clinical trials covering:Liver cancer，Esophageal cancer，Lung cancer，Breast cancer，Cervical cancer，Pancreatic cancer，High-grade gliomas，Adenoid cystic carcinoma of head and neck.
For patients participating in these trials, the hospital provides research grants to expert teams to cover their heavy ion treatment costs, creating a dual empowerment model where "patient benefit" and "technological advancement" reinforce each other.
This innovative approach breaks traditional research barriers, accelerating the establishment of national standardized protocols for complex cancers. It transforms clinical techniques into evidence-based guidelines, offering a "Chinese Solution" for global standardization and precision in heavy ion therapy—writing a new chapter in safeguarding human health through rigorous clinical research.
Knowledge Compendium
Book Series Propels a New Era in Heavy Ion Medicine
As heavy ion medical technology advances globally, the construction and sharing of knowledge systems serve as the core driver of industry transformation. Anchored in its mission to "forge industry standards and disseminate cutting-edge wisdom," the Heavy Ion Center at Gansu Wuwei Cancer Hospital has meticulously compiled and promoted a groundbreaking series of publications:
- 《Radiation Safety Management and Equipment Operation Guidelines for Heavy Ion Therapy》
- 《Standard Operating Procedures for Carbon Ion Radiotherapy》
- 《Precision Tumor Radiotherapy: Carbon Ion Therapy Series (Physics Volume)》
- 《Precision Tumor Radiotherapy: Carbon Ion Therapy Series (Technical Volume)》
- 《Precision Tumor Radiotherapy: Carbon Ion Therapy Series (Clinical Volume)》
- 《TCM Constitution Classification and Health Management》
- 《Practical Handbook of Oncology Hospital Management Systems》
- 《Comprehensive Lifecycle Rehabilitation Management for Cancer Patients》
- 《A Multidimensional Perspective on Carbon Ion Cancer Therapy》
This collection empowers medical professionals to scientifically apply heavy ion therapy and enables patients to make informed treatment decisions.
Adopting an interdisciplinary, full-chain perspective, the series systematically addresses:
✔ Physical technical specifications
✔ Clinical operation standards
✔ Physician practice guidelines
✔ Holistic health management frameworks
Not only does it crystallize the center’s five years of clinical and research breakthroughs, but it also fills a critical gap in China’s standardized heavy ion medical knowledge system.
These initiatives mark China’s transition from technological pioneer to standard-setter in heavy ion medicine. Through the power of open knowledge sharing, they inject innovative vitality into global oncology care, steering the industry toward high-quality development.
Global Synergy
Building a Heavy Ion Medical Community with a Shared Future
Amidst the tide of global medical collaboration, the Heavy Ion Center at Gansu Wuwei Cancer Hospital has adopted a forward-looking strategic vision to construct a worldwide heavy ion medical alliance network, facilitating cross-regional and interdisciplinary flows of high-quality medical resources.
The center is fully advancing its established Heavy Ion Therapy Alliance and 50 expert workstations, delivering premium medical services directly to patients' doorsteps while solidifying the foundation for high-quality development at both the Wuwei and Lanzhou centers.
This innovative model achieves:
✔ Efficient decentralization of premium medical resources
✔ Standardized advancement of heavy ion therapy through:
Regular academic exchanges
Case study symposiums
Cross-institutional technical collaboration
Leveraging this global alliance network, the center continues to:
Deepen partnerships with world-leading medical institutions
Integrate cutting-edge theories and innovative technologies
Inject sustained momentum into high-quality development
Simultaneously, it offers a "Chinese Solution" for the coordinated global progress of heavy ion medicine, demonstrating China’s commitment to fostering a global community of health for all.
Gathering Excellence
Building a Global Talent Hub for Heavy Ion Medicine
Talent serves as the core engine driving medical innovation. With a strategic vision to "converge global expertise and empower Healthy China," the Heavy Ion Center at Gansu Wuwei Cancer Hospital has established an internationally diverse team of top-tier experts.
The center has long-term collaborations with:
- Prof. Tatsumi Kanai (Gunma University Faculty of Medicine, Japan)
- Prof. Hirohiko Tsujii (Former Director, NIRS, Japan)
- Prof. Jörg Hauffe (Former Director, RPTC Munich, Germany)
- Prof. Olga (RPTC Munich, Germany)
- Prof. Yi-Min Jen (Former Chair, TAROG, Taiwan)
- Prof. Chia-Ming Wu (Leading Medical Physicist, Chang Gung Memorial Hospital, Taiwan)
- Prof. Junjie Wang's Team (Chair, CSRO, China)
Recently, it further strengthened its talent pool by recruiting:
- Prof. Yasuo Yoshioka (Radiation Oncology, NCC Japan)
- Prof. György Kovács (Director, Lubeck Brachytherapy Center, Germany / Education Director, UCSC Italy)
- Prof. Tung-Ho Wu (Proton Center, TMU Hospital, Taiwan)
This multidisciplinary think tank integrates Eastern and Western expertise across the entire heavy ion therapy chain, creating an unparalleled knowledge matrix.
The powerhouse team has:
✔ Elevated academic influence and technical innovation at Wuwei Center
✔ Fueled global oncology progress through its "talent-driven institution" strategy
✔ Pioneered transformative chapters in safeguarding human health
Prof. Tatsumi Kanai, Faculty of Medicine, Gunma University, Japan
Prof. Hirohiko Tsujii, Former Director, National Institute of Radiological Sciences (NIRS), Japan
Prof. Jörg Hauffe, Former Medical Director, Rinecker Proton Therapy Center (RPTC), Munich, Germany
Prof. Olga, RPTC Munich, Germany
Former Chairman, Taiwanese Association for Radiation Oncology (TARO),Prof. Jia-Ming Wu
Distinguished Medical Physicist, Department of Radiation Oncology,Chang Gung Memorial Hospital, Taiwan
Prof. Junjie Wang，Chairman, Radiation Oncology Society，Chinese Medical Association (CMA)
The Heavy Ion Center of Gansu Wuwei Cancer Hospital has achieved a historic leap from catching up to leading the global anti-cancer battlefield.Multiple "world-first" technological breakthroughs have not only reshaped the landscape of cancer treatment, but also demonstrated to the world the formidable strength and national responsibility of China's medical capabilities.
Looking ahead, the center remains anchored in the "Healthy China 2030" strategy, with the courage to break barriers and stand at the forefront of innovation. It continues to advance the intelligent, precise and standardized development of heavy ion technology.Focusing on building an internationally top-tier research hub, perfecting whole-life-cycle health service systems, and promoting Chinese standards globally, the center is writing a new chapter in safeguarding human health with Chinese wisdom, injecting powerful momentum into building a global community of health for all.